Cite
HARVARD Citation
Catlett, I. et al. (n.d.). 225 An oral, selective inhibitor of tyrosine kinase 2, BMS-986165, improves molecular, cellular, and clinical biomarkers associated with efficacy in moderate to severe psoriasis. Lupus science & medicine. p. A169. [Online].